These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27364045)

  • 21. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
    Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients.
    Arbustini E; Merlini G; Gavazzi A; Grasso M; Diegoli M; Fasani R; Bellotti V; Marinone G; Morbini P; Dal Bello B
    Am Heart J; 1995 Sep; 130(3 Pt 1):528-36. PubMed ID: 7661071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
    Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
    JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid in endomyocardial biopsies.
    Kieninger B; Eriksson M; Kandolf R; Schnabel PA; Schönland S; Kristen AV; Hegenbart U; Lohse P; Röcken C
    Virchows Arch; 2010 May; 456(5):523-32. PubMed ID: 20376481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
    Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.
    Siegismund CS; Escher F; Lassner D; Kühl U; Gross U; Fruhwald F; Wenzel P; Münzel T; Frey N; Linke RP; Schultheiss HP
    Eur J Heart Fail; 2018 Apr; 20(4):751-757. PubMed ID: 29067795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
    Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis.
    Gama F; Rosmini S; Bandula S; Patel KP; Massa P; Tobon-Gomez C; Ecke K; Stroud T; Condron M; Thornton GD; Bennett JB; Wechelakar A; Gillmore JD; Whelan C; Lachmann H; Taylor SA; Pugliese F; Fontana M; Moon JC; Hawkins PN; Treibel TA
    JACC Cardiovasc Imaging; 2022 Dec; 15(12):2082-2094. PubMed ID: 36274040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between monoclonal gammopathy and cardiac amyloid type.
    Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
    Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis.
    Wan K; Sun J; Han Y; Liu H; Yang D; Li W; Wang J; Cheng W; Zhang Q; Zeng Z; Chen Y
    Circ J; 2018 Feb; 82(3):739-746. PubMed ID: 29093431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
    Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
    Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
    Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
    Barison A; Aquaro GD; Pugliese NR; Cappelli F; Chiappino S; Vergaro G; Mirizzi G; Todiere G; Passino C; Masci PG; Perfetto F; Emdin M
    J Intern Med; 2015 May; 277(5):605-14. PubMed ID: 25346163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
    Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
    Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction.
    Helder MR; Schaff HV; Nishimura RA; Gersh BJ; Dearani JA; Ommen SR; Mereuta OM; Theis JD; Dogan A; Edwards WD
    Am J Cardiol; 2014 Nov; 114(9):1396-9. PubMed ID: 25217455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.